FLGT Q2 2019 Earnings — Fulgent Genetics, Inc. Revenue & Financial Results | Market Cap Arena

FLGTFulgent Genetics, Inc.

$447M

Q2 2019 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$8M+56.0% YoY

Gross Profit

$5M57.0% margin

Operating Income

$295,0003.5% margin

Net Income

$331,0003.9% margin

EPS (Diluted)

$0.02

QoQ Revenue Growth

+56.9%

Cash Flow

Operating Cash Flow

$675,000

Free Cash Flow

$176,000

Stock-Based Comp.

$737,000

Balance Sheet

Total Assets

$56M

Total Liabilities

$5M

Stockholders' Equity

$51M

Cash & Equivalents

$9M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$5M	+56.0%
Gross Profit	$5M	$3M	+68.2%
Operating Income	$295,000	-$1M	+129.5%
Net Income	$331,000	-$1M	+131.6%

Geographic Segments

UNITED STATES

$7M79%

Other Countries

$1M15%

CANADA

$516,0006%